Page 12 of 83
Previous Page     Next Page        Smaller fonts | Larger fonts     Go back to the flash version

12

nanotimes Companies

Companies – Summaries Facts

3

M Health Care (NYSE: MMM) announced the introduction of a full line of new, innovative

Tegaderm™ High Performance Foam Adhesive Dressings. In clinical and laboratory tests, these new adhesive foam wound dressings outperform other leading foam adhesive dressings in managing the full range of low- to high-moisture conditions that can be present in chronic and acute wounds.

3M has completed its acquisition of PolyFab Inc., a manufacturer of thermal and acoustic insulation for the aerospace industry. MTI PolyFab designs and manufactures a light-weight thermal and acoustic insulation system for a wide variety of aerospace customers to address unwanted airborne and struc- ture-borne noise in aircraft. The combination of MTI PolyFab products with those of 3M’s wholly-owned subsidiary, Aearo Technologies LLC, will provide a comprehensive range of solutions to the aerospace industry.

http://www.3M.com a

ap Implantate AG, a German medical techno- logy company, achieved in the first quarter of the

fiscal year 2010 sales at product level of EUR5.7 mil- lion. Disregarding project sales, sales in the Analytics division that was sold in December 2009, and other one-time factors totaling EUR2.4 million, compara- ble product sales in the first quarter of 2009 were EUR5.9 million. That leaves Q1 2010 sales EUR 0.2 million, or 3%, down on Q1 2009. http://www.aap.de

full year ended March 31, 2010. Revenue for the quarter increased 4% to $20.8 million from $20.0 million for the same quarter of the previous year. Revenue for the year ended March 31, 2010 incre- ased 2% to $83.0 million from $81.0 million for the previous year. Non-GAAP net loss was ($0.6) million, or ($0.02) per diluted share, for the three months en- ded March 31, 2010 compared to ($1.5) million, or ($0.05) per diluted share, for the same quarter of the previous year. Non-GAAP net income was $6.6 mil- lion, or $0.24 per diluted share, for the year ended March 31, 2010 compared to $6.0 million, or $0.22 per diluted share, for the previous year.

A

The Company’s balance sheet as of March 31, 2010 included cash, cash equivalents, marketable secu- rities and restricted cash of $93.1 million. Deferred revenue at the end of the fourth quarter was $61.3 million, up 7% from March 31, 2009. The Company has no debt outstanding. http://www.accelrys.com

rage systems for clean, efficient power and energy management, reported financial results for the first quarter ended March 31, 2010.

A

Recent Highlights • Continued Altair‘s long-term supply relationship

ltair Nanotechnologies, Inc. (Altairnano, NASDAQ: ALTI), a provider of energy sto-

ccelrys, Inc. (NASDAQ: ACCL) reported financial results for the fourth fiscal quarter and

10-05/06 :: May/June 2010

Previous arrowPrevious Page     Next PageNext arrow        Smaller fonts | Larger fonts     Go back to the flash version
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27  |  28  |  29  |  30  |  31  |  32  |  33  |  34  |  35  |  36  |  37  |  38  |  39  |  40  |  41  |  42  |  43  |  44  |  45  |  46  |  47  |  48  |  49  |  50  |  51  |  52  |  53  |  54  |  55  |  56  |  57  |  58  |  59  |  60  |  61  |  62  |  63  |  64  |  65  |  66  |  67  |  68  |  69  |  70  |  71  |  72  |  73  |  74  |  75  |  76  |  77  |  78  |  79  |  80  |  81  |  82  |  83